293 related articles for article (PubMed ID: 26464014)
1. A systematic review and critical assessment of incentive strategies for discovery and development of novel antibiotics.
Renwick MJ; Brogan DM; Mossialos E
J Antibiot (Tokyo); 2016 Feb; 69(2):73-88. PubMed ID: 26464014
[TBL] [Abstract][Full Text] [Related]
2. Antibiotic research and development: business as usual?
Harbarth S; Theuretzbacher U; Hackett J;
J Antimicrob Chemother; 2015; 70(6):1604-7. PubMed ID: 25673635
[TBL] [Abstract][Full Text] [Related]
3. Antibiotic innovation for future public health needs.
Theuretzbacher U
Clin Microbiol Infect; 2017 Oct; 23(10):713-717. PubMed ID: 28652114
[TBL] [Abstract][Full Text] [Related]
4. Incentives for new antibiotics: the Options Market for Antibiotics (OMA) model.
Brogan DM; Mossialos E
Global Health; 2013 Nov; 9():58. PubMed ID: 24199835
[TBL] [Abstract][Full Text] [Related]
5. (Inter)nationalising the antibiotic research and development pipeline.
Singer AC; Kirchhelle C; Roberts AP
Lancet Infect Dis; 2020 Feb; 20(2):e54-e62. PubMed ID: 31753765
[TBL] [Abstract][Full Text] [Related]
6. Antibiotic development - economic, regulatory and societal challenges.
Årdal C; Balasegaram M; Laxminarayan R; McAdams D; Outterson K; Rex JH; Sumpradit N
Nat Rev Microbiol; 2020 May; 18(5):267-274. PubMed ID: 31745330
[No Abstract] [Full Text] [Related]
7. A call for antibiotic alternatives research.
Stanton TB
Trends Microbiol; 2013 Mar; 21(3):111-3. PubMed ID: 23473628
[TBL] [Abstract][Full Text] [Related]
8. Economic Incentives for Antibacterial Drug Development: Literature Review and Considerations From the Transatlantic Task Force on Antimicrobial Resistance.
Sciarretta K; Røttingen JA; Opalska A; Van Hengel AJ; Larsen J
Clin Infect Dis; 2016 Dec; 63(11):1470-1474. PubMed ID: 27578820
[TBL] [Abstract][Full Text] [Related]
9. Sources of novel antibiotics--aside the common roads.
Donadio S; Maffioli S; Monciardini P; Sosio M; Jabes D
Appl Microbiol Biotechnol; 2010 Dec; 88(6):1261-7. PubMed ID: 20865256
[TBL] [Abstract][Full Text] [Related]
10. Systems, not pills: The options market for antibiotics seeks to rejuvenate the antibiotic pipeline.
Brogan DM; Mossialos E
Soc Sci Med; 2016 Feb; 151():167-72. PubMed ID: 26808335
[TBL] [Abstract][Full Text] [Related]
11. Healthcare-associated infections, infection control and the potential of new antibiotics in development in the USA.
Amin AN; Deruelle D
Future Microbiol; 2015; 10(6):1049-62. PubMed ID: 26059625
[TBL] [Abstract][Full Text] [Related]
12. Encouraging the Development of New Antibiotics: Are Financial Incentives the Right Way Forward? A Systematic Review and Case Study.
Dutescu IA; Hillier SA
Infect Drug Resist; 2021; 14():415-434. PubMed ID: 33574682
[TBL] [Abstract][Full Text] [Related]
13. Incentivising innovation in antibiotic drug discovery and development: progress, challenges and next steps.
Simpkin VL; Renwick MJ; Kelly R; Mossialos E
J Antibiot (Tokyo); 2017 Dec; 70(12):1087-1096. PubMed ID: 29089600
[TBL] [Abstract][Full Text] [Related]
14. Encouraging Sustainable Use of Antibiotics: A Commentary on the DRIVE-AB Recommended Innovation Incentives.
Morel CM; Edwards SE
J Law Med Ethics; 2018 Jun; 46(1_suppl):75-80. PubMed ID: 30146962
[TBL] [Abstract][Full Text] [Related]
15. Should financial incentives be used to differentially reward 'me-too' and innovative drugs?
Pekarsky B
Pharmacoeconomics; 2010; 28(1):1-17. PubMed ID: 20014872
[TBL] [Abstract][Full Text] [Related]
16. Overcoming the current deadlock in antibiotic research.
Schäberle TF; Hack IM
Trends Microbiol; 2014 Apr; 22(4):165-7. PubMed ID: 24698433
[TBL] [Abstract][Full Text] [Related]
17. Funding Antibiotic Innovation With Vouchers: Recommendations On How To Strengthen A Flawed Incentive Policy.
Outterson K; McDonnell A
Health Aff (Millwood); 2016 May; 35(5):784-90. PubMed ID: 27140983
[TBL] [Abstract][Full Text] [Related]
18. Antibiotics in late clinical development.
Fernandes P; Martens E
Biochem Pharmacol; 2017 Jun; 133():152-163. PubMed ID: 27687641
[TBL] [Abstract][Full Text] [Related]
19. Antibiotic drug discovery.
Wohlleben W; Mast Y; Stegmann E; Ziemert N
Microb Biotechnol; 2016 Sep; 9(5):541-8. PubMed ID: 27470984
[TBL] [Abstract][Full Text] [Related]
20. Antibiotic discovery in the twenty-first century: current trends and future perspectives.
Donadio S; Maffioli S; Monciardini P; Sosio M; Jabes D
J Antibiot (Tokyo); 2010 Aug; 63(8):423-30. PubMed ID: 20551985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
